Get started
Author

Nicole A. Karras

Observed names: N A Karras, N.A. Karras, Nicole A Karras, Nicole Karras
OpenAlex ID: A5087115676
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
2021 · Vanessa A. Fabrizio, Jaap Jan Boelens, et al. · Blood Advances · 119
PDF
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
2019 · Kasiani C Myers, Elissa Furutani, et al. · The Lancet Haematology · 119
Denosumab Treatment of Metastatic Giant-Cell Tumor of Bone in a 10-Year-Old Girl
2013 · Nicole A. Karras, Lynda E. Polgreen, et al. · Journal of Clinical Oncology · 84
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report
2021 · Vanessa A. Fabrizio, Christine L. Phillips, et al. · Blood Advances · 78
PDF
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia
2022 · Liora M. Schultz, Anne Eaton, et al. · Journal of Clinical Oncology · 72
PDF
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
2022 · Amy Moskop, Lauren Pommert, et al. · Blood Advances · 66
PDF
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
2012 · Nicole A. Karras, Matthew Weeres, et al. · Transplantation and Cellular Therapy · 66
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant
2021 · Monzr M. Al Malki, Ni-Chun Tsai, et al. · Blood Advances · 61
HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease
2017 · Anna B. Pawlowska, Jerry C. Cheng, et al. · Transplantation and Cellular Therapy · 51
PDF
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
2018 · Weili Sun, Huaying Liu, et al. · Journal of Hematology & Oncology · 50
PDF
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
2022 · Heather E. Stefanski, Anne Eaton, et al. · Blood Advances · 49
Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC)
2020 · Liora M. Schultz, Christina Baggott, et al. · Blood · 38
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
2023 · Kevin O. McNerney, Stephanie J. Si Lim, et al. · Blood Advances · 32
PDF
Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation
2021 · Stephanie Mac, Dat Ngo, et al. · Bone Marrow Transplantation · 20
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy
2025 · Hannah Lust, Liora M. Schultz, et al. · Blood Advances · 18
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
2024 · Ibrahim Aldoss, Haoyue Shan, et al. · Transplantation and Cellular Therapy · 16
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
2023 · Chenyu Lin, Aurelie Schwarzbach, et al. · Transplantation and Cellular Therapy · 16
PDF
Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience
2020 · Justine A. Ross, Nicole A. Karras, et al. · Journal of Pediatric Hematology/Oncology · 16
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
2023 · Valentin Barsan, Yimei Li, et al. · EClinicalMedicine · 14
PDF
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia
2021 · Jenna Rossoff, Christina Baggott, et al. · Blood · 14
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
2021 · Alex F. Herrera, Joycelynne Palmer, et al. · Blood Advances · 13
PDF
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD)
2013 · N Gossai, M R Verneris, et al. · Bone Marrow Transplantation · 13
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy
2023 · Paul Szabolcs, Roei D. Mazor, et al. · Transplantation and Cellular Therapy · 10
Hurricane Katrina's Impact on Pediatric and Adult Patients with Sickle Cell Disease
2007 · Nicole A Karras, Charles S Hemenway · Journal of Health Care for the Poor and Underserved · 10
Real-World Treatment of Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Using Tisagenlecleucel That Is out of Specification for Commercial Release
2020 · Jenna Rossoff, Christina Baggott, et al. · Blood · 8
Works count: 83
Citation count: 1,156
H-index: 16
I10-index: 24
Year
Topic
Type